FibroBiologics Inc’s recent filing unveils that its Chief Scientific Officer Khoja Hamid acquired Company’s shares for reported $16800.0 on May 27 ’25. In the deal valued at $0.84 per share,20,000 shares were bought. As a result of this transaction, Khoja Hamid now holds 31,250 shares worth roughly $15312.5.
Rodman & Renshaw initiated its FibroBiologics Inc [FBLG] rating to a Buy in a research note published on December 12, 2024; the price target was $12. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Maxim Group began covering FBLG with “Buy” recommendation on September 24, 2024.
Price Performance Review of FBLG
On Tuesday, FibroBiologics Inc [NASDAQ:FBLG] saw its stock fall -10.82% to $0.49. Over the last five days, the stock has lost -10.22%. FibroBiologics Inc shares have fallen nearly -81.49% since the year began. Nevertheless, the stocks have fallen -75.48% over the past one year. While a 52-week high of $3.89 was reached on 01/07/25, a 52-week low of $0.51 was recorded on 10/07/25.
Levels Of Support And Resistance For FBLG Stock
The 24-hour chart illustrates a support level at 0.4636, which if violated will result in even more drops to 0.4368. On the upside, there is a resistance level at 0.5436. A further resistance level may holdings at 0.5968.
How much short interest is there in FibroBiologics Inc?
A steep rise in short interest was recorded in FibroBiologics Inc stocks on 2025-09-15, dropping by -0.13 million shares to a total of 0.97 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 1.1 million shares. There was a decline of -13.19%, which implies that there is a negative sentiment for the stock.
